v3.25.2
Insider Trading Arrangements
3 Months Ended
Jun. 30, 2025
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

During the quarter ended June 30, 2025, an officer (as defined in Exchange Act Rule 16a-1(f)) of the Company adopted a written plan for the sale of the Company’s common shares intended to satisfy the affirmative defense conditions of Exchange Act Rule 10b5-1(c) (“Rule 10b5-1 trading arrangements”) as follows:

 

On May 12, 2025, Kristopher R. Westbrooks, President and Chief Operating Officer, adopted a 10b5-1 trading arrangement that provides for the potential sale of up to 12,000 common shares, as well as up to 12,104 common shares acquired upon exercise of stock options, which trading arrangement is scheduled to start no earlier than September 10, 2025 and terminate no later than March 10, 2026.

On May 23, 2025, Kevin Raketich, Executive Vice President and Chief Commercial Officer, adopted a 10b5-1 trading arrangement that provides for the potential sale of up to 20,000 common shares, as well as up to 16,000 common shares acquired upon exercise of stock options, which trading arrangement is scheduled to start no earlier than August 22, 2025 and terminate no later than March 31, 2026.

 

On May 23, 2025, Kristine C. Syrvalin, Executive Vice President, General Counsel and Chief Human Resources Officer, adopted a 10b5-1 trading arrangement that provides for the potential sale of up to 12,500 common shares, as well as up to 4,452 common shares acquired upon exercise of stock options, which trading arrangement is scheduled to start no earlier than September 4, 2025 and terminate no later than March 6, 2026.

 

On May 23, 2025, Michael S. Williams, Chief Executive Officer, adopted a 10b5-1 trading arrangement that provides for the potential sale of up to 100,000 common shares, acquired upon exercise of stock options, which trading arrangement is scheduled to start no earlier than September 22, 2025 and terminate no later than March 31, 2026.

 

Each of the above-named officers is currently and is expected to remain in compliance with his or her share ownership guidelines following the sale of any common shares pursuant to his or her 10b5-1 trading arrangement.

Kevin Raketich [Member]  
Trading Arrangements, by Individual  
Name Kevin Raketich
Title Executive Vice President and Chief Commercial Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date May 23, 2025
Aggregate Available 20,000
Kristine C. Syrvalin [Member]  
Trading Arrangements, by Individual  
Name Kristine C. Syrvalin
Title Executive Vice President, General Counsel and Chief Human Resources Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date May 23, 2025
Aggregate Available 12,500
Kristopher R. Westbrooks [Member]  
Trading Arrangements, by Individual  
Name Kristopher R. Westbrooks
Title President and Chief Operating Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date May 12, 2025
Aggregate Available 12,000
Michael S. Williams [Member]  
Trading Arrangements, by Individual  
Name Michael S. Williams
Title Chief Executive Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date May 23, 2025
Aggregate Available 100,000
Kevin Raketich Trading Arrangement Common Sale [Member] | Kevin Raketich [Member]  
Trading Arrangements, by Individual  
Aggregate Available 16,000
Kristine C. Syrvalin Trading Arrangement Common Sale [Member] | Kristine C. Syrvalin [Member]  
Trading Arrangements, by Individual  
Aggregate Available 4,452
Kristopher R. Westbrooks Trading Arrangement Common Sale [Member] | Kristopher R. Westbrooks [Member]  
Trading Arrangements, by Individual  
Aggregate Available 12,104